Navigation Links
Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial
Date:5/21/2009

Universal Definition of Myocardial Infarction provided jointly by leading international cardiology societies

TOKYO and INDIANAPOLIS, May 21 /PRNewswire-FirstCall/ -- Investigators from the Phase III TRITON-TIMI 38 study applied the new classification system for the Universal Definition of Myocardial Infarction to the results of the study and showed that patients with acute coronary syndromes (ACS) undergoing percutaneous coronary intervention (PCI) and taking prasugrel, as compared with patients taking clopidogrel (Plavix(R)/Iscover(R)), experienced reduced risk of heart attack regardless of heart-attack type (procedural related or spontaneous), size or timing over a 15-month period. The new Universal Definition of Myocardial Infarction (1) was developed in 2007 by the Joint European Society of Cardiology, American College of Cardiology, American Heart Association and the World Heart Federation Task Force. This post hoc analysis was published in Circulation online on May 18, 2009.(2)

In this post hoc analysis, the incidence of non-procedural heart attack in patients treated with prasugrel compared with patients treated with clopidogrel was 2.8 percent vs. 3.7 percent, respectively (p=0.0013). The risk of procedure-related heart attacks was 4.9 percent in patients who took prasugrel compared with 6.4 percent in patients who took clopidogrel (p=0.0002). Non-procedure-related heart attacks included spontaneous heart attacks, which could be differentiated from procedure-related heart attacks that were associated with the artery-opening procedure known as PCI, or with stent thrombosis.

The analysis reported in this paper was not pre-specified in the TRITON-TIMI 38 study because the Universal Definition of Myocardial Infarction was published after the trial started.

"Our findings provide a more complete characterization of the effect of prasugrel on new or recurrent heart attacks," said David A. M
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
2. BioMS Medicals pivotal international multiple sclerosis trial receives positive review from Data Safety Monitoring Board
3. Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models
4. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
5. Biovista Inc. Announces Positive Efficacy Results in a Pre-Clinical Trial of its BVA-101 Repositioned Drug for Multiple Sclerosis
6. Intrinsic Bioprobes, Inc. Enters into a $1.27M Contract with the National Cancer Institute to Develop Multiplex Mass Spectrometric Immunoassays for Detection of Low Abundance Cancer-Related Proteins
7. First Multiple Dose Clinical Trial of TorreyPines Therapeutics Oral Compound NGX426 Demonstrates Compound Is Safe and Well-Tolerated
8. BioMS Medical reports results of exploratory phase II trial of dirucotide in relapsing remitting multiple sclerosis
9. International Guidelines for First-Line use of Freelite(TM) in Diagnosis and Management of Multiple Myeloma to be Published in "Leukemia"
10. Proteolix Announces Positive Data From Two Ongoing Phase 2 Clinical Trials of Carfilzomib in Multiple Myeloma at the 50th Annual Meeting of the American Society of Hematology
11. EntreMed Initiates ENMD-2076 Clinical Trial in Multiple Myeloma

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...ire-USNewswire/ -- The Michael J. Fox Foundation f...5 million in total awards to six research teams wo...rapies for Parkinson,s disease. The funding was aw...y for Parkinson,s Disease program, made possible ... ), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009).../ -- Dr. Jessica Torrente, Assistant Professor of ...Center in Washington, D.C., demonstrated the integ...SGI) in clinical practice as an adjunct imaging mo... the annual meeting of the Radiological Society of...xhibit was to demonstrate how BSGI is used in the ...
(Date:11/30/2009)... in providing smart and efficient software to the ...reg;, evolutionizing work-from-home histopathology... software used by 8 of the Top 10 Pharmaceutical C...ide’ basis. , Mount...s announced another evolution in the histopatholog...
(Date:11/30/2009)...er 30 ApaTech, the rapidly growing...t growing,Biotech/Pharmaceutical/Medical Technolog...y Fast 500 for EMEA (Europe, Middle East and Afric...ompanies, five-year revenue growth,for which ApaT.... This,achievement places ApaTech 9th overall in t...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
...PPLICATION NOTE , , Cathy Olsen,...s Dr., , Sunnyvale, CA 94089. , ...The Molecular Devices SpectraMax M5 and, ...microplate readers whose detection modes include,... have dual, monochromators, so the optimi...
... Application Guide .........................................................................2 , ........................................................, II. Product Components ................................................................2 ,...
...urification of Endotoxin-Free Plasmid DNA , ,D... HP Endotoxin-Free Plasmid Maxiprep,Kit offers a...in-free plasmid DNA. A patent-pending,endotoxin ...t streamlined protocol available for purifying,h....,This product delivers significant time-savings...
Other Biology Technology:measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 2measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 3measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 4measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 5measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 6measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 7measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 8measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 9measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 10measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 11measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 12measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 13measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 14measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay 15Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 2Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 3Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 4Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 5Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 6Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 7Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 8Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue 9Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 2Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 3Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 4Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 5
(Date:11/30/2009)...rom The Forsyth Institute, the University of Conne...nter, have used state-of-the-art technology to elu...lidum, the bacterium which causes syphilis. The pr...a can now be shown in three dimensions. This provi...ls previously unknown features, which may help fig...
(Date:11/30/2009)...rchers from LSU Health Sciences Center New Orleans...ational Institute of Child Health and Human Develo...igham and Women,s Hospital, and Harvard Medical Sc...more than 5 servings of sugar- sweetened cola a we...vate the risk of developing diabetes during pregna...
(Date:11/30/2009)...naugural Global Conference on Systems & Enterprise...gton, DC, focuses on the convergence of complex la...rtance to society. , The goal of the confere...round targeted complex systems, examined by domain...s Critical Infrastructure Systems, including Intel...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 1Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 2Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 3Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 4Top 10 Tips for Alzheimer 26apos 3Bs Caregivers 61036 1Top 10 Tips for Alzheimer 26apos 3Bs Caregivers 61036 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 1Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 2Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 3
...p-selling laundry products and air fresheners foun...ls. All six products tested gave off at least one ...eral laws, but none of those chemicals was listed ...n this topic because people were telling me that t...t from laundry products vented outdoors were makin...
...e working on new ways of storing CO 2 emissions u...ming. , The University has launched the Carbon St...ly-created position of Professor of Carbon Capture...to find efficient and reliable ways of gathering C...ng it in former oil and gas fields or aquifers ind...
...om the lower abdomen and inner thigh through lipos... cells, with higher stem cell concentrations than ... study in August,s Plastic and Reconstructive Sur...n Society of Plastic Surgeons (ASPS). This is the ...sues from different areas of the body vary in stem...
Other Biology News:Toxic chemicals found in common scented laundry products, air fresheners 2Toxic chemicals found in common scented laundry products, air fresheners 3Durham scientists to tackle CO2 storage in global warming challenge 2Want a reason to love your lower belly fat? It's rich in stem cells 2
Normal Chicken Serum from Equitech-Bio
Mouse Anti-Human HAPLN1 Monoclonal Antibody, Unconjugated, Clone 316119 from R&D Systems
Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON
SEQUENASE PCR PRODUCT PRE-SEQU from GE Healthcare, formerly Amersham Biosciences
Biology Products: